Bon Natural Life (BON) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Regencell Bioscience is the larger company by market cap ($3.64 billion vs $9.5 million), about 384.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BON | RGC |
|---|---|---|
| Share price | $1.16 | $7.35 |
| Market cap | $9.48M | $3.64B |
| 1-day change | -0.62% | -3.67% |
| YTD return | — | -63.67% |
| 1-year return | — | -60.67% |
| 5-year return | — | +1455.56% |
| Forward P/E | 2.00 | — |
| EPS (TTM) | $-2.79 | $-0.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $2.34 | $69.00 |
| 52-week low | $0.95 | $4.51 |
| Distance from 52-week high | -50.43% | -89.35% |
| Average volume | 7.96K | 199.19K |
| Shares outstanding | 6.13M | 495.88M |
| Employees | 96 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Regencell Bioscience is about 384.6 times larger than Bon Natural Life by market value ($3.64B vs $9.48M).
About Bon Natural Life
BON stock →Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements.
Health Care · Medicinal Chemicals and Botanical Products · 96 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
BON vs RGC FAQ
Which is bigger, Bon Natural Life or Regencell Bioscience?
Regencell Bioscience (RGC) is larger, with a market capitalization of $3.64B compared with $9.48M for Bon Natural Life (BON).
Are Bon Natural Life and Regencell Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.